| __timestamp | Arrowhead Pharmaceuticals, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 75334000 |
| Thursday, January 1, 2015 | 382000 | 135057000 |
| Friday, January 1, 2016 | 158333 | 146691000 |
| Sunday, January 1, 2017 | 31407709 | 316613000 |
| Monday, January 1, 2018 | 16142321 | 151862000 |
| Tuesday, January 1, 2019 | 168795577 | 195992000 |
| Wednesday, January 1, 2020 | 87992066 | 267594000 |
| Friday, January 1, 2021 | 138287000 | 443310000 |
| Saturday, January 1, 2022 | 243231000 | 660116000 |
| Sunday, January 1, 2023 | 240735000 | 829253000 |
| Monday, January 1, 2024 | 3551000 | 1015324000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Halozyme Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc. have shown contrasting revenue trajectories. From 2014 to 2023, Halozyme's revenue surged by over 1,000%, peaking at approximately $829 million in 2023. This remarkable growth reflects their strategic advancements in drug delivery technologies.
Conversely, Arrowhead Pharmaceuticals experienced a more modest revenue increase, with a peak of around $243 million in 2022. Despite a dip in 2023, their focus on RNA interference therapeutics continues to hold promise. Notably, 2024 data for Halozyme is missing, indicating potential reporting delays or strategic shifts.
These trends highlight the diverse strategies and market responses of these biotech firms, offering valuable insights for investors and industry analysts alike.
Amgen Inc. or Halozyme Therapeutics, Inc.: Who Leads in Yearly Revenue?
Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Zoetis Inc. or Halozyme Therapeutics, Inc.?
Regeneron Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis
United Therapeutics Corporation and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: BioMarin Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Cytokinetics, Incorporated and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Telix Pharmaceuticals Limited and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Who Generates More Revenue? ACADIA Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.
Annual Revenue Comparison: Arrowhead Pharmaceuticals, Inc. vs Mesoblast Limited
Annual Revenue Comparison: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.